Children submitted to fetoscopic in utero myelomeningocele repair using the SAFER (Skin-over-biocellulose for Anternatal FEtoscopic Repair) technique will evaluate at 30 months or more, regarding ambulation, neurodevelopment, urinary and fecal status.
Children submitted to fetoscopic in utero myelomeningocele repair using the SAFER (Skin-over-biocellulose for Anternatal FEtoscopic Repair) technique will evaluate the neuropsicomotor development at 30 months of chronological age. The mental evaluation will use the Bayley III and thePEDI neurodevelopmental scale. The motor development will use the difference between anatomic and motor level of the lesion. Urinary and fecal continence will be evaluated using clinical and ultrasonographic parameters. For the anatomical level determination, immaging of the spine at the lesion level will be used. Motor level and ambulation will be evaluated through standard clinical examination.
Study Type
OBSERVATIONAL
Enrollment
30
Children will be evaluated trough Bayley III and PEDI scale. They also will be examined by pediatrician, neurosurgeon, orthopedics and phisiatry
Hospital Israelita Albert Einstein
São Paulo, São Paulo, Brazil
Hydrocephalus treatment - shunt or ETV
Need to treat hydrocephaly in the first year of life
Time frame: 12 months corrected age or more
Ambulation
Ambulation Status
Time frame: 30 months of cronological age or more
Neurodevelopmental test
PEDI scale will be performed
Time frame: 30 months of cronogical age or more
Anatomical verus motor level
To compare anatomical level with motor level
Time frame: 30 months of cronological age or more
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.